Fierce Biotech April 29, 2024
LumaBridge has promoted Todd Lehman to CEO, the oncology clinical research organization announced April 25. He was appointed the company’s president in January and was previously vice president and head of business development.
Lehman came to LumaBridge in 2023 after about a decade in various operations roles at PPD, the clinical research business of Thermo Fisher Scientific. His resume also includes leadership roles at Alcon Laboratories and Sirion Therapeutics, which, during his time there, evolved from a CRO to a biotech with five ophthalmology assets and two marketing approvals, according to LumaBridge’s website. He’s also a triathlete who served...
Today's Sponsors
Today's Sponsor